JPRN-UMIN000029029已完成未知
International Breast Cancer Biomarker, Standard of Care and Real World Outcomes Study - BREAKOUT
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Previous enrolment in this study. 2. Involvement in the planning and/or conduct of this study (applies to both AstraZeneca staff and/or staff at the study site). 3. Current participation in a clinical study with an investigational oncology product. 4. Previous PARPi therapy, including, but not limited to, participation in a previous clinical study that included PARPi therapy. 5. Current commencement of PARPi treatment.
研究者
相似试验
已完成
不适用
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyBreast CancerNCT03078036AstraZeneca873
进行中（未招募）
不适用
Breast cancer biomarkers and treatment targetsMalignant neoplasm of breastBreast cancerCancerISRCTN40576403niversity Hospital Southampton (UK)500
尚未招募
不适用
Biomarker detection for benign breast diseases and primary breast cancer by serum and tissue protein profiling.benign breast diseases10006291breast cancerNL-OMON30316Slotervaartziekenhuis380
已完成
3 期
ANZ 02P2 / International Breast cancer Intervention Study: IBIS-II Bone Sub-ProtocolOsteoporosisACTRN12605000222640Australia and New Zealand Breast Cancer Trials Group1,000
已完成
不适用
Bone Scan Index for Breast Cancer Bone MetastasisPatients with breast cacner and bone metastasisJPRN-UMIN000016868CSPOR-BC200